Transcatheter/Hybrid Aortic Valves in the Young
Tài liệu tham khảo
Cribier, 2002, Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description, Circulation, 106, 3006, 10.1161/01.CIR.0000047200.36165.B8
Vahanian, 2012, Guidelines on the management of valvular heart disease: the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), Eur J Cardiothorac Surg, 42, S1, 10.1093/ejcts/ezs455
Walther, 2011, Transcatheter aortic valve implantation transapical: step by step, Semin Thorac Cardiovasc Surg, 23, 55, 10.1053/j.semtcvs.2011.05.006
Willson, 2011, Transfemoral aortic valve replacement with the SAPIEN XT valve: step-by-step, Semin Thorac Cardiovasc Surg, 23, 51, 10.1053/j.semtcvs.2011.04.005
Kempfert, 2011, The evolution of transapical aortic valve implantation and new perspectives, Minim Invasive Ther Allied Technol, 20, 107, 10.3109/13645706.2011.558101
Webb, 2014, Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve, J Am Coll Cardiol, 64, 2235, 10.1016/j.jacc.2014.09.026
Piazza, 2014, First-in-human experience with the Medtronic CoreValve Evolut R, EuroIntervention, 9, 1260, 10.4244/EIJV9I11A215
Kempfert, 2012, Symetis ACURATE TA valve, EuroIntervention, Q102, 10.4244/EIJV8SQA19
Möllmann, 2013, Symetis ACURATE TF aortic bioprosthesis, EuroIntervention, 9, S107, 10.4244/EIJV9SSA22
Kempfert, 2014, First registry results from the newly approved ACURATE TA TAVI system, Eur J Cardiothorac Surg, 367, 11
Seiffert, 2014, Initial German experience with transapical implantation of a second-generation transcatheter heart valve for the treatment of aortic regurgitation, JACC Cardiovasc Interv, 7, 1168, 10.1016/j.jcin.2014.05.014
Treede, 2012, JenaValve, EuroIntervention, 8, Q88, 10.4244/EIJV8SQA16
Rudolph, 2013, JenaValve--transfemoral technology, EuroIntervention, 9, S101, 10.4244/EIJV9SSA20
Holzhey, 2013, Intermediate follow-up results from the multicenter engager European pivotal trial, Ann Thorac Surg, 96, 2095, 10.1016/j.athoracsur.2013.06.089
Willson, 2012, Transcatheter aortic valve replacement with the St. Jude Medical Portico valve: first-in-human experience, J Am Coll Cardiol, 60, 581, 10.1016/j.jacc.2012.02.045
Manoharan, 2012, St Jude medical portico valve, EuroIntervention, 8, Q97, 10.4244/EIJV8SQA18
Cheung, 2013, St. Jude medical portico transapical technology, EuroIntervention, 9, S103, 10.4244/EIJV9SSA21
Meredith, 2014, Transfemoral aortic valve replacement with the repositionable Lotus Valve System in high surgical risk patients: the REPRISE I study, EuroIntervention, 9, 1264, 10.4244/EIJV9I11A216
Meredith, 2014, Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study, J Am Coll Cardiol, 64, 1339, 10.1016/j.jacc.2014.05.067
Schofer, 2014, Prospective multicenter evaluation of the direct flow medical transcatheter aortic valve, J Am Coll Cardiol, 63, 763, 10.1016/j.jacc.2013.10.013
Smith, 2011, Transcatheter versus surgical aortic-valve replacement in high-risk patients, 364, 2187
Adams, 2014, Transcatheter aortic-valve replacement with a self-expanding prosthesis, N Engl J Med, 370, 1790, 10.1056/NEJMoa1400590
Kapadia, 2014, Long-term outcomes of inoperable patients with aortic stenosis randomly assigned to transcatheter aortic valve replacement or standard therapy, Circulation, 130, 1483, 10.1161/CIRCULATIONAHA.114.009834
Kodali, 2012, Two-year outcomes after transcatheter or surgical aortic-valve replacement, N Engl J Med, 366, 1686, 10.1056/NEJMoa1200384
Popma, 2014, Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery, J Am Coll Cardiol, 63, 1972, 10.1016/j.jacc.2014.02.556
Cribier, 2014, Patient selection for TAVI in 2014: is it justified to treat low- or intermediate-risk patients? The cardiologist׳s view, EuroIntervention, 10, U16, 10.4244/EIJV10SUA3
Reynolds, 2012, Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A), J Am Coll Cardiol, 60, 2683, 10.1016/j.jacc.2012.09.018
Mohr, 2014, The German Aortic Valve Registry: 1-year results from 13,680 patients with aortic valve disease, Eur J Cardiothorac Surg, 46, 808, 10.1093/ejcts/ezu290
Eusanio, 2015, Sutureless aortic valve replacement, Ann Cardiothorac Surg, 4, 123
Munretto, 2015, Treating the patients in the grey zone with aortic valve disease: a comparison among conventional surgery, sutureless valves and transcatheter aortic valve replacement, Interact Cardiovasc Thorac Surg, 20, 90, 10.1093/icvts/ivu340
Santarpino, 2014, Sutureless replacement versus transcatheter valve implantation in aortic valve stenosis: a propensity-matched analysis of 2 strategies in high-risk patients, J Thorac Cardiovasc Surg, 147, 561, 10.1016/j.jtcvs.2013.10.025
D’Onofrio, 2013, Conventional surgery, sutureless valves and transapical aortic valve replacement: what is the best option for patients with aortic stenosis? A multicenter, propensity-matched analysis, J Cardiovasc Surg, 146, 1065
